BNR vs. OCFT, RR, DOMA, AIXI, ARRW, ZENV, ALLT, PSNL, RCAT, and FAAS
Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include OneConnect Financial Technology (OCFT), Richtech Robotics (RR), Doma (DOMA), Xiao-I (AIXI), Arrowroot Acquisition (ARRW), Zenvia (ZENV), Allot Communications (ALLT), Personalis (PSNL), Red Cat (RCAT), and DigiAsia (FAAS).
Burning Rock Biotech (NASDAQ:BNR) and OneConnect Financial Technology (NYSE:OCFT) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, community ranking, analyst recommendations, media sentiment, profitability, institutional ownership and risk.
OneConnect Financial Technology has a net margin of -9.90% compared to Burning Rock Biotech's net margin of -121.79%. OneConnect Financial Technology's return on equity of -11.80% beat Burning Rock Biotech's return on equity.
OneConnect Financial Technology has a consensus price target of $5.25, suggesting a potential upside of 125.32%. Given OneConnect Financial Technology's higher probable upside, analysts plainly believe OneConnect Financial Technology is more favorable than Burning Rock Biotech.
In the previous week, Burning Rock Biotech had 1 more articles in the media than OneConnect Financial Technology. MarketBeat recorded 3 mentions for Burning Rock Biotech and 2 mentions for OneConnect Financial Technology. Burning Rock Biotech's average media sentiment score of 0.70 beat OneConnect Financial Technology's score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the media.
Burning Rock Biotech has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500. Comparatively, OneConnect Financial Technology has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.
OneConnect Financial Technology received 4 more outperform votes than Burning Rock Biotech when rated by MarketBeat users. Likewise, 40.91% of users gave OneConnect Financial Technology an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote.
30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 4.1% of OneConnect Financial Technology shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
OneConnect Financial Technology has lower revenue, but higher earnings than Burning Rock Biotech. OneConnect Financial Technology is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.
Summary
OneConnect Financial Technology beats Burning Rock Biotech on 11 of the 17 factors compared between the two stocks.
Get Burning Rock Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Burning Rock Biotech Competitors List
Related Companies and Tools
